Stacy Ku

Work Performance Price Targets & Ratings Chart

Analyst Stacy Ku, currently employed at TD COWEN, carries an average stock price target met ratio of 50% that have a potential upside of 64.95% achieved within 247 days.

Stacy Ku’s has documented 26 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SUPN, Supernus Pharmaceuticals at 23-Oct-2025.

Wall Street Analyst Stacy Ku

Analyst best performing recommendations are on VRCA (VERRICA PHARMACEUTICALS).
The best stock recommendation documented was for VRCA (VERRICA PHARMACEUTICALS) at 10/21/2024. The price target of $10 was fulfilled within 15 days with a profit of $5.7 (36.31%) receiving and performance score of 24.2.

Average potential price target upside

of $24.43 (232.6%) on ATXS (ASTRIA THERAPEUTICS).
of $3.76 (56.3%) on AUPH (AURINIA PHARMACEUTICALS).

ATXS Astria Therapeutics AUPH Aurinia Pharmaceuticals BCRX BioCryst Pharmaceuticals KALV Kalvista Pharmaceuticals LENZ LENZ Therapeutics SUPN Supernus Pharmaceuticals VRCA Verrica Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Steven Seedhouse (CANTOR FITZGERALD)